Trial intelligence / Profile preview

Tretinoin Gel Microsphere vs Retin-A Micro in Acne Vulgaris

NCT04883736Phase 1Completed

Start
Aug 2020
Primary completion
Apr 2021
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, randomised, double-blind trial of tretinoin in acne vulgaris (3 arms). Primary endpoint: Percentage change in the inflammatory and non-inflammatory lesion counts at 12 weeks. Started Aug 2020; status: completed.

02

Drugs

tretinoin
03

Conditions

acne vulgaris

Beyond the preview

Go deeper on NCT04883736.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04883736.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call